Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised

Safety and preliminary activity of pembrolizumab‑carboplatin

Biomedicines, Free Full-Text

Primary chemoradiation with cisplatin versus cetuximab for locally

PDF) First-line treatment with chemotherapy plus cetuximab in

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil

Cancers, Free Full-Text

Immunotherapy in head and neck squamous cell carcinoma and rare

Systemic Treatment Sequencing and Prediction of First-line Therapy

Systemic Treatment Sequencing and Prediction of First-line Therapy

First‐line cetuximab + platinum‐based therapy for recurrent

PDF) Induction Docetaxel, Cisplatin, and Cetuximab Followed by

GEDEFO on X: Docetaxel can be substituted for 5-FU in combination